Azopt

Azopt is a prescription ophthalmic suspension containing brinzolamide 1% w/v, supplied in a 5 mL bottle. Classified as an antiglaucoma agent, it carries DIN 02238873 and is available by prescription in Canada and Quebec. Each millilitre delivers 10 mg of brinzolamide in a sterile suspension. The formulation includes mannitol, carbomer 974P, sodium chloride, edetate sodium, tyloxapol, hydrochloric acid and/or sodium hydroxide for pH adjustment, and purified water.